Pharmacy & Therapeutics - February 2009 - (Page 56)

CONTENTS Cover: DNA double helix. See Meeting Highlights from the American Society of Human Genetics on page 92. (Copyright © D. A. Wagner Productions LLC / Phototake. All rights reserved.) February 2009 FEATURES COMMENTARY Pushing an Expanded Role for Pharmacists 78 DEPARTMENTS Editorial 61 David B. Nash, MD, MBA, describes the goals of the National Quality Forum in improving health care in six key areas as well as eliminating unnecessary services. Medication Errors 62 Matthew Grissinger, RPh, FASCP, explains how patients can be harmed when glacial (pure) acetic acid, instead of a diluted form, is dispensed. Prescription: Washington 65 Stephen Barlas discusses the long-simmering debate over the content of consumer medication information. New Drugs/Drug News/ New Medical Devices 67 From Mozobil to Zolpimist, P&T presents the latest studies and information about FDA approvals, new indications, recalls, and industry updates. Drug Forecast 73 Hoyee Leong, PhD, and Mary Ellen Bonk, PharmD, review bendamustine (Treanda), a therapy for chronic lymphocytic leukemia. Medicare, SCHIP, and Health Insurance Debates Present Ample Opportunities With a new administration in place, pharmacists may play a larger advisory role. Stephen Barlas Better Asthma Management with Advanced Technology Creation of an Asthma Utilization Rx Analyzer (AURA) Tool The AURA tool enables health plans to evaluate quality and use of resources for their members with asthma by analyzing medical and pharmacy claims. 80 James H. Jackson, PharmD, MPH; Benjamin Gutierrez, PhD; Orsolya E. Lunacsek, PhD, MBA; and Sulabha Ramachandran, PhD Pharmaceutical Approval Update Products include fospropofol for sedation; plerixafor to prepare patients for transplantation; and fenofibric acid for improving triglycerides and cholesterol. Marvin M. Goldenberg, PhD, RPh, MS MEETING HIGHLIGHTS 86 58th Annual Meeting, American Society of Human Genetics, 2008 The authors report on a project to sequence the genomes of more than 1,000 people; Gaucher’s disease; warfarin genetics; and Huntington’s disease. Safiya Abouzaid, PharmD; Joseph E. Couto, PharmD, MBA; and Marc B. Royo 92 American Society of Hematology, 50th Annual Meeting and Exposition Topics include leukemias, myelodysplastic disorder, multiple myeloma, parox- 96 ysmal nocturnal hemoglobinuria, and idiopathic thrombocytopenic purpura. 2008 San Antonio Breast Cancer Symposium Summaries discuss zoledronic acid, everolimus, lapatinib, and letrozole. Walter Alexander BOOK REVIEW 101 Stahl’s Essential Psychopharmacology, 3rd Edition Reviewed by David A. Casey, MD 104 107 Author Guidelines 56 P&T® • February 2009 • Vol. 34 No. 2

Table of Contents Feed for the Digital Edition of Pharmacy & Therapeutics - February 2009

Pharmacy & Therapeutics - February 2009 Contents Editorial Medication Errors Prescription: Washington New Drugs/Drug News/New Medical Devices Drug Forecast Pushing an Expanded Role for Pharmacists Better Asthma Management with Advanced Technology Pharmaceutical Approval Update 58th Annual Meeting, American Society of Human Genetics, 2008 American Society of Hematology, 50th Annual Meeting and Exposition 2008 San Antonio Breast Cancer Symposium Stahl’s Essential Psychopharmacology, 3rd Edition Author Guidelines

Pharmacy & Therapeutics - February 2009

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.